concentrations of total thyroxine (TT 4 ) or free T 4 and thyroid stimulating hormone (TSH). A low plasma TT 4 concentration is a sensitive variable for diagnosing hypothyroidism in dogs. 2 However, a number of factors other than the intrinsic thyroid function can affect the circulating TT 4 concentration, such as certain drugs and nonthyroidal illnesses (NTI). 1, 3, 4 A low plasma TT 4 combined with a high plasma TSH confirms primary hypothyroidism. However, 30%-38% 5, 6 of hypothyroid dogs have a plasma TSH concentration within the reference range. Consequently, a low plasma TT 4 concentration in combination with a plasma TSH concentration within the reference range does not distinguish between hypothyroidism and NTI.
To overcome this problem, other tests for diagnosing hypothyroidism are required. A TSH response test, using recombinant human TSH (rhTSH), is considered the gold standard. 7 But, even though rhTSH can be aliquoted and frozen for 4-8 weeks, 8 the high costs of the formulation prevent it from being a good diagnostic option for veterinary practitioners. The circulating free T 4 concentration is more specific than the plasma TT 4 concentration but less sensitive 9 and several free T 4 assays are not reliable. 10 Detection of antibodies against thyroglobulin does not prove that the dog has or will develop hypothyroidism 11 and negative results occur in dogs with hypothyroidism. 12 Histologic examination of thyroid tissue is regarded as the definitive test to identify thyroid disease, but taking thyroid biopsies is invasive and the presence of a lesion does not necessarily prove the existence of a functional abnormality. 13 Imaging Another interesting observation is that hypothyroidism in dogs with a plasma TSH concentration above the reference range is associated with increased release of growth hormone (GH). 17, 18 Moreover, plasma GH concentration increases significantly after TRH administration in these dogs with hypothyroidism, whereas this increase is absent in euthyroid dogs. 17 The aim of our study was to evaluate whether a basal plasma GH In addition, locomotion problems (lameness, stiff gait; n 5 9), myxedema (tragic facial expression; n 5 7), excessive snoring (n 5 5), and a preference for warm places (n 5 3) were noticed. At presentation, the time from onset of the signs ranged from 3 weeks to 2 years. All dogs were client-owned and owners signed an informed consent. analysis. Subsequently, the samples were centrifuged at 48C and plasma samples were stored at 2708C until analysis.
| 99m TcO

| Assays
Plasma TSH concentrations were determined by a homologous solidphase, two-site chemiluminescent enzyme immunometric assay (Immulite 2000 canine TSH, Siemens), in accordance with the instruction of the manufacturer and as described previously. 19 The intra-assay coefficients of variation were 5.0 and 4.0% at TSH concentrations of 0.20 and 0.50 mg/L, respectively. The interassay coefficient of variation was 6.3% at a TSH concentration of 0.16 mg/L. The detection limit of the TSH assay was 0.03 mg/L.
Plasma GH concentrations were determined by a homologous radioimmunoassay, as described earlier. 20 The intra-and inter-assay coefficients of variation were 3.8 and 7.2%, respectively, and the sensitivity was 0.3 mg/L. 
| R E SULTS
Based on thyroid scintigraphy, 11 dogs were diagnosed with hypothyroidism and ten were classified as dogs with NTI. There were no significant differences in baseline characteristics between the hypothyroid and NTI dogs, except for sex. There were significantly (P 5 .013) more males in the hypothyroid group than in the NTI group. Receiver operating characteristic curve analysis revealed that at T 5 45 a GH/TSH ratio > 4.60 corresponded with hypothyroidism and a value < 4.60 with NTI. because it is only available in a few referral centers, since specialist equipment and radiation-isolation facilities are required.
| D ISCUSSION
In our study, the basal plasma GH concentration was increased in the hypothyroid dogs, which is in accordance with previous studies in hypothyroid dogs with a plasma TSH concentration above the reference range. 18, 22 In contrast, in some mammals, such as sheep, primary hypothyroidism does not seem to affect GH secretion, 23 whereas in humans, rats and pigs primary hypothyroidism is associated with low circulating GH concentrations. [24] [25] [26] [27] [28] The human and rat pituitary GH gene contains a positive thyroid hormone response element (TRE), 29 and as a consequence the low thyroid hormone concentrations of hypothyroidism will result in low expression of pituitary GH in these species. Indeed, in hypothyroid rats decreased pituitary content of both GH mRNA and GH protein have been reported. 25, 27 The lack of a decrease in GH release in dogs with primary hypothyroidism might be explained by the absence of a positive TRE within the canine GH gene, as sequence analysis of the promoter region and intron 1 of the canine GH gene has not demonstrated the existence of a TRE in this species. 30 Apart from direct effects on transcription of the GH gene, hypothyroidism might affect pituitary GH release via an influence on the hypothalamic hormones somatostatin and TRH. Somatostatin is not only the main inhibitory factor for pituitary GH release, but also the main inhibitory factor for pituitary TSH release. In case of primary hypothyroidism, the decreased feedback signal from thyroid hormones on the hypothalamic-pituitary axis should result in increased pituitary TSH production and release, which might be partly mediated by less somatostatin secretion, which will also result in less suppression of GH release.
The decreased feedback signal from thyroid hormones on the hypothalamic-pituitary axis will not only result in less somatostatin secretion, but also in more TRH secretion. This increased TRH secretion might be one of the reasons for the increased basal plasma GH concentration in our hypothyroid dogs. In healthy humans and euthyroid rats administration of TRH elicits no or only a small transient rise in plasma GH concentrations, whereas in humans and rats with primary hypothyroidism TRH administration results also in significantly increased plasma GH concentrations. 31, 32 Similarly, TRH administration caused a paradoxical rise in plasma GH concentrations in our hypothyroid dogs, as described previously. 17 The aim of our study was to investigate whether basal and TRHinduced plasma GH concentrations can be used to differentiate As may be expected, TRH administration resulted in a significant increase in the plasma TSH concentration in the NTI dogs. However, a significant TRH-induced increase in plasma TSH concentration was absent in the hypothyroid dogs. This lack of TSH response to TRH stimulation in our hypothyroid dogs has been reported before. 5, 17, 34 An explanation for this lack of TSH increase upon TRH stimulation has been suggested to be exhaustion of thyrotropes 35 or desensitization for TRH stimulation. 22 Another possibility is that with time isoforms of TSH are produced that are not measured by the available TSH assays. 5 By using the percentage increase in plasma TSH concentration after TRH administration, a complete distinction between hypothyroid dogs and NTI dogs was found.
Taking into account the opposite effects of TRH administration on circulating concentrations of GH and TSH in the NTI dogs and hypothyroid dogs, we calculated the ratio between GH and TSH. Using a cut-off value for the GH/TSH ratio of 4.60, the distinction between the NTI dogs and hypothyroid dogs was even more clear than with only the plasma GH concentration.
The data from our study are promising but research in a larger cohort of dogs is needed to further verify the usability and reliability of the TRH stimulation test as a method of differentiating primary hypothyroidism and NTI in dogs. For example, in some dogs with NTI, such as during sulfonamide treatment 4 and in dogs with untreated hypoadrenocorticism 36 an increased circulating TSH concentration may be present, and it would be interesting to investigate the effects of TRH administration in these dogs. Furthermore, it might be that dogs with a low plasma T 4 concentration because of hypercortisolism, that is, dogs with NTI, will have a limited response in plasma TSH concentration after TRH administration. 37 
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